nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case for imaging in high-risk psychosis: insular pathology in first episode psychosis
|
Kasinathan, John |
|
2017 |
51 |
10 |
p. 1057-1058 |
artikel |
2 |
An Erudite Encounter with: Paul Mullen
|
Mullen, Paul |
|
2017 |
51 |
10 |
p. 1062-1063 |
artikel |
3 |
Are there adverse effects associated with mindfulness?
|
Van Gordon, William |
|
2017 |
51 |
10 |
p. 977-979 |
artikel |
4 |
Clinically relevant changes in clozapine serum concentrations after breast reduction surgery
|
Schoretsanitis, Georgios |
|
2017 |
51 |
10 |
p. 1059-1060 |
artikel |
5 |
Commentary on McGorry PD (2017), Back to the future: Schizophrenia in retrospect and prospect
|
Jablensky, Assen |
|
2017 |
51 |
10 |
p. 1052-1053 |
artikel |
6 |
Escitalopram induced thrombocytopenia reversed after shifting to bupropion in a depressive patient
|
Chu, Ching-Wen |
|
2017 |
51 |
10 |
p. 1055-1056 |
artikel |
7 |
Impact of social disadvantage and parental offending on rates of criminal offending among offspring of women with severe mental illness
|
Valuri, Giulietta Maria |
|
2017 |
51 |
10 |
p. 1032-1040 |
artikel |
8 |
Is it time for child psychiatry to grow up?
|
Thabrew, Hiran |
|
2017 |
51 |
10 |
p. 971-973 |
artikel |
9 |
Lithium in ANZJP: A fifty-year follow-up study!
|
Malhi, Gin S. |
|
2017 |
51 |
10 |
p. 965-970 |
artikel |
10 |
Lurasidone associated neutropenia
|
Singh, Sarvesh |
|
2017 |
51 |
10 |
p. 1055 |
artikel |
11 |
‘Medical’ marijuana is incompatible with mental health promotion
|
Chopra, Prem |
|
2017 |
51 |
10 |
p. 1060-1061 |
artikel |
12 |
Olanzapine modulates the default-mode network homogeneity in recurrent drug-free schizophrenia at rest
|
Guo, Wenbin |
|
2017 |
51 |
10 |
p. 1000-1009 |
artikel |
13 |
Psychotropic medication use in Australia, 2007 to 2015: Changes in annual incidence, prevalence and treatment exposure
|
Brett, Jonathan |
|
2017 |
51 |
10 |
p. 990-999 |
artikel |
14 |
Re: Meta-analysis of Australian Indigenous psychiatric treatment, critiqued
|
Leske, Stuart |
|
2017 |
51 |
10 |
p. 1053-1054 |
artikel |
15 |
Risks, benefits and finding the best way forward
|
Galletly, Cherrie |
|
2017 |
51 |
10 |
p. 963-964 |
artikel |
16 |
Schizoaffective disorder, catatonia and white matter changes – Revisiting the microglial hypothesis
|
Tibrewal, Prashant |
|
2017 |
51 |
10 |
p. 1056-1057 |
artikel |
17 |
Sexual dimorphism of the planum temporale in schizophrenia: A MRI study
|
Delvecchio, Giuseppe |
|
2017 |
51 |
10 |
p. 1010-1019 |
artikel |
18 |
Striving for balance between participation and protection in research involving prison populations
|
Spencer, Sarah-Jane |
|
2017 |
51 |
10 |
p. 974-976 |
artikel |
19 |
Suicide in 19th-century Australian fiction
|
Pridmore, Saxby |
|
2017 |
51 |
10 |
p. 1058-1059 |
artikel |
20 |
Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations
|
Myles, Nicholas |
|
2017 |
51 |
10 |
p. 980-989 |
artikel |
21 |
Ventricular volumes across stages of schizophrenia and other psychoses
|
Berger, Gregor E |
|
2017 |
51 |
10 |
p. 1041-1051 |
artikel |
22 |
White matter deficits in schizophrenia are global and don’t progress with age
|
Kanaan, Richard A |
|
2017 |
51 |
10 |
p. 1020-1031 |
artikel |